USFDA approves Rapamune for high-risk kidney transplants
Rapamune OK'd for high-risk transplants
United Press International
2/2/2007 5:33:00 PM -0500
The U.S. Food and Drug Administration Friday expanded the labeling of Wyeth's anti-rejection drug Rapamune for high-risk kidney transplants.
Click here for complete article.
United Press International
2/2/2007 5:33:00 PM -0500
The U.S. Food and Drug Administration Friday expanded the labeling of Wyeth's anti-rejection drug Rapamune for high-risk kidney transplants.
Click here for complete article.
No comments:
Post a Comment